|
Delivering the promise of Personalized Medicine today
Genomic Healthcare Strategies is a company that works both as a consulting firm and on teams that create new companies. Our sole focus is on personalized medicine and personalized health and wellness, broadly defined.
We believe that the new science and new insights derived from molecular medicine (e.g., genomics, proteomics, metabolomics) are fundamentally changing healthcare in the US and around the world.
To quote FDA commissioner Andrew von Eschenbach: "...that transformation [to molecular medicine]...is so profound and so radical that I call it a metamorphosis: a molecular metamorphosis in which the future of health and healthcare will be no more like the past than a butterfly is like a caterpillar. It is that radical. It is that profound. And it will alter and change not just one thing; it will change everything."
GHS works with a range of companies, from Fortune 100 firms to venture-funded start-ups. In all cases we help firms deploy their resources in order to succeed in the rapidly changing personalized medicine market.
|
